Cart
sales@molnova.com
Diclofensine
CAS No. 67165-56-4
Diclofensine( Ro 8-4650 )
Catalog No. M20755 CAS No. 67165-56-4
Diclofensine inhibits the uptake of serotonin noradrenaline and dopamine.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 43 | In Stock |
|
| 10MG | 73 | In Stock |
|
| 25MG | 132 | In Stock |
|
| 50MG | 200 | In Stock |
|
| 100MG | 300 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameDiclofensine
-
NoteResearch use only, not for human use.
-
Brief DescriptionDiclofensine inhibits the uptake of serotonin noradrenaline and dopamine.
-
DescriptionDiclofensine inhibits the uptake of serotonin noradrenaline and dopamine.
-
In Vitro——
-
In Vivo——
-
SynonymsRo 8-4650
-
PathwayMembrane Transporter/Ion Channel
-
TargetMonoamine Transporter
-
RecptorMonoamine transporter
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number67165-56-4
-
Formula Weight322.2
-
Molecular FormulaC17H17Cl2NO
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCOc1ccc2C(CN(C)Cc2c1)c1ccc(Cl)c(Cl)c1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Cherpillod C Omer L M O . A Controlled Trial with Diclofensine a New Psychoactive Drug in the Treatment of Depression[J]. Journal of International Medical Research 1981 9(5):324-329.
molnova catalog
related products
-
Atomoxetine hydrochl...
A selective norepinephrine (NE) transporter inhibitor with Ki of 5 nM; shows weak affinity for 5-HT and dopamine transporters with IC50 of 77 and 1,451 nM, respectively.
-
FFN 206 dihydrochlor...
FFN 206 dihydrochloride is a fluorescent VMAT2 substrate that can be used to detect VMAT2 subcellular sites in cell culture and shows no detectable inhibition of DAT.
-
Paroxetine hydrochlo...
An antidepressant of the selective serotonin reuptake inhibitor (SSRI) class; also shows to be a selective inhibitor of GRK2 activity both in vitro and in living cells.
